N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride CAS:211914-50-0

Antiviral Medications: N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride holds promise as a candidate for antiviral drugs. It may exhibit inhibitory effects against viral replication, making it a potential asset in the development of treatments for viral infections such as influenza, HIV, and hepatitis. Antiparasitic Agents: The compound's properties suggest potential applications in the development of antiparasitic medications. It may be effective against various parasitic infections, including malaria, leishmaniasis, and trypanosomiasis. Research is underway to explore its efficacy in combating these debilitating diseases. Central Nervous System (CNS) Drugs: This compound may have implications in the development of CNS drugs, particularly in the treatment of neurological disorders such as epilepsy, neuropathic pain, and anxiety. Its pharmacological properties and potential for modulating neuronal pathways make it an area of interest for therapeutic interventions in these conditions. Immunomodulatory Therapies: N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride could be explored for its immunomodulatory effects. It may have the potential to modulate immune responses, making it a candidate for treating autoimmune diseases or for use in immunotherapy approaches. Gastrointestinal Treatments: The compound could be investigated for its potential in gastrointestinal medicine. Its pharmacological properties may lend themselves to addressing conditions such as inflammatory bowel disease, irritable bowel syndrome, and peptic ulcers, offering new treatment options for patients with these disorders. Pharmacological Research Tools: Due to its complex structure and potential biological activities, this compound can serve as a valuable tool in pharmacological research. It can be utilized to study biochemical pathways, cellular processes, and drug-receptor interactions, providing insights into drug discovery and development. When utilizing N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride in pharmaceutical development, it is crucial to adhere to strict regulatory guidelines, safety standards, and ethical considerations. Comprehensive preclinical and clinical studies are essential to evaluate its pharmacokinetics, efficacy, and safety profile to ensure its suitability for various therapeutic applications.